Director, International Business And Product
CurrentRegions: China, South East Asia, Middle East, Europe etc.Product management, marketing and business development of product lines including tumor early screening, cancer companion diagnostics, recurrence monitoring, pathogen detection, etc. Market leader of Liver cancer early screening in China: HCCscreen, an NGS based test designated as FDA breakthrough device; and HCCscan (CE-IVD marked), a qPCR based kit expected to be the first NMPA approved test for HCC screening purpose. Penetrated into multiple screening scenarios including but not limited to hospitals, health checkups, government supported screening, insurance etc.